IBI3020

· Innovent Biopharmaceutical Technology (Hangzhou) Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IBI3020, covering 2025-06-06 to 2025-06-06. Get the full timeline:

Most recent: Clinical Trial Update: Study of IBI3020 Treatment in Participants With Late-Stage Solid Tumors [Phase 1]